Zhi Fu
Impact in
-
- Heavy Metal Exposure and Toxicity
- Mercury impact and mitigation studies
-
- Vitamin C and Antioxidants Research
- Trace Elements in Health
Papers in
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
Zhi Fu
19 papers receiving 328 citations
Peers
Comparison fields: 5 of 83
- Health, Toxicology and Mutagenesis 52
- Nutrition and Dietetics 42
- Developmental Neuroscience 10
- Pathology and Forensic Medicine 41
- Cancer Research 31
Countries citing papers authored by Zhi Fu
This map shows the geographic impact of Zhi Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Fu more than expected).
Fields of papers citing papers by Zhi Fu
This network shows the impact of papers produced by Zhi Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Fu. The network helps show where Zhi Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhi Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | Low Expression of BIRC5-206 Promotes Cancer Progression in Nasopharyngeal Carcinoma via Enhancing Expression of Stem Cell Markers. | 2023 | 2 |
| 4 | 2022 | 3 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 18 | |
| 7 | 2020 | 3 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 19 | |
| 10 | 2020 | 30 | |
| 11 | Luteolin suppresses tumor proliferation through inducing apoptosis and autophagy via MAPK activation in glioma | 2019 | 4 |
| 12 | 2019 | 30 | |
| 13 | 2018 | 4 | |
| 14 | 2017 | 28 | |
| 15 | 2017 | 29 | |
| 16 | 2016 | 6 | |
| 17 | 2016 | 123 | |
| 18 | 2011 | 15 | |
| 19 | Construction and Application of a Large Scale cDNA Sequences Analysis System Based on Unix | 2002 | 1 |
About Zhi Fu
Zhi Fu is a scholar working on Cancer Research, Pathology and Forensic Medicine, Urology, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis, having authored 19 papers that have together received 334 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), IL-33, ST2, and ILC Pathways (2 papers), MicroRNA in disease regulation (2 papers), Ferroptosis and cancer prognosis (2 papers), Asthma and respiratory diseases (2 papers), Heavy Metal Exposure and Toxicity (2 papers), Air Quality and Health Impacts (1 paper) and Aortic Disease and Treatment Approaches (1 paper). The work is most often cited by research in Health, Toxicology and Mutagenesis (52 citations), Nutrition and Dietetics (42 citations), Developmental Neuroscience (10 citations), Pathology and Forensic Medicine (41 citations) and Cancer Research (31 citations). Zhi Fu has collaborated with scholars based in China. Frequent co-authors include Kai Zhou, Hesuyuan Huang, Xuming Mo, Xiaodong Zang, Di Yu, Long Wang, Xuming Mo, Cheng Xu, Changgui Lu and Qiuju Huang. Their work appears in journals such as Medicine, Scientific Reports, International Archives of Allergy and Immunology, The Annals of Thoracic Surgery and Journal of Environmental Pathology Toxicology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.